Variable | IABP group (N = 34) | Control group (N = 33) | p-value effect IABP | p-value effect | ||||
---|---|---|---|---|---|---|---|---|
T1 | T2 | T3 | T1 | T2 | T3 | T1–T3 | ||
EtCO2 (mmHg) | 33.1 ± 3,6 | 33.1 ± 3.2 | 31.1 ± 3.4* | 34.7 ± 4.9 | 34.2 ± 4.0 | 33.0 ± 3.1* | 0.809 | 0.004 |
Mean BP (mmHg) | 91.1 ± 13.3 | 83.2 ± 13.4* | 89.0 ± 9.1 | 93.5 ± 13.6 | 80.4 ± 12.1* | 90.3 ± 8.3 | 0.853 | < 0.001 |
Systolic (BP mmHg) | 132.9 ± 20.3 | 127.0 ± 23.6* | 127.3 ± 18.3* | 138.1 ± 22.7 | 128.2 ± 17.2* | 125.8 ± 16.8* | 0.629 | 0.007 |
Diastolic BP (mmHg) | 67.9 ± 10.9 | 46.2 ± 13.9*# | 67.9 ± 8.7* | 69.4 ± 10.7 | 58.6 ± 11.7* | 70.7 ± 8.6* | 0.003 | < 0.001 |
HR (bpm) | 68.4 ± 11.4 | 103.8 ± 17.0* | 89.2 ± 15.9* | 61.9 ± 9.1 | 101.9 ± 13.0* | 90.5 ± 12.5* | 0.304 | < 0.001 |
ARI | 5.5 ± 1,9 | 4.0 ± 1.9* | 5.7 ± 2.0 | 5.7 ± 1.7 | 4.1 ± 1.6* | 5.7 ± 1.6 | 0.978 | < 0.001 |
ARI < 4 (n, %) | 7 (20.6%) | 18 (52.9%)* | 7 (20.5%) | 5 (15.1%) | 17 (51.5%)* | 4 (12.1%) | 0.138 | < 0.001 |
CBFV MCA (cm/s) | 57.3 ± 19.4 | 74.0 ± 21.6* | 71.1 ± 21.3* | 59.3 ± 11.8 | 74.7 ± 17.5* | 68.1 ± 15.1* | 0.952 | < 0.001 |
Systolic CBFV (cm/s) | 89.1 ± 28.5 | 107.6 ± 32.5* | 109.6 ± 30.2* | 90.6 ± 20.5 | 113.3 ± 24.7* | 101.1 ± 22.2* | 0.942 | < 0.001 |
Diastolic CBFV (cm/s) | 39.9 ± 11.4 | 33.2 ± 14.4*# | 49.0 ± 21.4 | 39.7 ± 8.2 | 51.5 ± 13.8 | 48.8 1 ± 0.8 | 0.001 | < 0.001 |
PI | 0.82 ± 0.15 | 1.03 ± 0.26*# | 0.85 ± 0.16 | 0.85 ± 0.17 | 0.84 ± 0.17 | 0.80 ± 0.18 | 0.001 | < 0.001 |